We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

We recently compiled a list of the 10 Firms Kick Off Trading Week Soaring. In this article, we are going to take a look at ...

Fintel reports that on January 23, 2025, Barclays initiated coverage of Guardant Health (NasdaqGS:GH) with a Overweight ...

Guardant Health, Inc. (NASDAQ:GH) announced that Palmetto GBA, a Medicare administrative contractor that administers the ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Demant (WILLF – Research Report) and ...

Despite Guardant Health's positive Q4 2024 report, it remains unprofitable with negative cash flow, unlike its peer Natera.

Guardant Health Inc (GH) stock saw a decline, ending the day at $47.21 which represents a decrease of $-1.39 or -2.86% from the prior close of $48.6. The stock opened at $48.26 and touched a low of ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on GH stock, giving a Buy rating yesterday.Invest with Confidence: ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data ...

Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood ...

In terms of valuation, Guardant Health Inc’s market capitalization stands at $6.00 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...

Investment analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for Guardant Health in a research report issued on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now ...